📉 The Financial Deep Dive
Yatharth Hospital & Trauma Care Services Limited has reported a strong set of unaudited financial results for the third quarter and nine months ended December 31, 2025. The company showcased significant year-on-year growth on a consolidated basis, signaling robust expansion in its healthcare services.
The Numbers:
Consolidated revenue from operations surged by 46.23% year-on-year (YoY) to ₹3,204.71 million in Q3 FY26, a substantial jump from ₹2,191.55 million in the prior year period. Consolidated Profit After Tax (PAT) followed suit, increasing by 41.30% YoY to ₹430.83 million, up from ₹304.91 million. Profit Before Tax (PBT) also grew robustly by 42.18% YoY to ₹570.97 million.
For the nine months ended December 31, 2025 (9MFY26), consolidated revenue rose 32.21% YoY to ₹8,576.63 million, while consolidated PAT saw a healthy increase of 37.62% YoY to ₹1,263.75 million.
However, the standalone performance presents a mixed picture. While standalone revenue grew by a notable 43.25% YoY to ₹1,581.50 million in Q3 FY26, the standalone PAT saw a significantly more modest increase of 7.37% YoY to ₹238.93 million. This disparity between consolidated and standalone PAT growth merits closer examination.
The Quality:
The company provided an update on its Qualified Institutional Placement (QIP) proceeds, indicating their strategic utilisation for debt repayment, hospital acquisitions, medical equipment purchases, and general corporate purposes. This suggests prudent capital management aimed at fueling future growth.
A key strategic development is the acquisition of Shantived Institute of Medical Sciences in Agra, Uttar Pradesh, effective February 01, 2026. This 150-bed facility (expandable to 250) underscores the company's aggressive expansion strategy within India's healthcare landscape.
The Grill:
The most critical point of analysis lies in the divergent growth rates of consolidated versus standalone PAT. While consolidated PAT grew by over 41%, standalone PAT grew by only 7.37% in Q3 FY26. This suggests that subsidiary operations or acquired entities are contributing disproportionately to the bottom line, or that standalone operational costs/expenses have increased significantly. Investors will be keen to understand the drivers behind this divergence.
Furthermore, the Income Tax Department's actions, including provisional attachments ordered in October 2023, have seen attachments on properties, bank deposits, and cash balances released during the quarter. While the company states that the Assessment Order for AY 2024-25 has been issued and an appeal filed, management expresses confidence that no material liability is expected. This remains an area of vigilance, as any adverse outcome could impact profitability.
🚩 Risks & Outlook
The acquisition of the Agra hospital is a significant growth driver, expanding Yatharth Hospital's geographical footprint and bed capacity. The successful integration and operational efficiency of this new facility will be crucial for its contribution to future earnings.
The Income Tax matter, though currently managed with an expectation of no material liability, presents an ongoing risk. The outcome of the appeal filed against the Assessment Order for AY 2024-25 will be closely watched.
The company's assessment of the four Labour Codes indicates no anticipated material financial impact based on current understanding, but continued monitoring of regulatory clarifications is prudent. The divergence in standalone versus consolidated profitability needs to be a focal point for management commentary in future calls, as it could signal underlying operational or financial dynamics within specific entities. The company operates within a single business segment ('Medical and Healthcare Services') and a single geographical segment ('India'), indicating a focused business strategy.